UNDERWRITING AGREEMENT between TITAN PHARMACEUTICALS, INC. and as Representative of the Several Underwriters TITAN PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 25th, 2018 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 25th, 2018 Company Industry JurisdictionThe undersigned, Titan Pharmaceuticals, Inc., a corporation formed under the laws of the State of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with A.G.P./Alliance Global Partners (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
and Continental Stock Transfer & Trust Company, as Warrant Agent Warrant Agency Agreement Dated as of September 25, 2018 WARRANT AGENCY AGREEMENTWarrant Agency Agreement • September 25th, 2018 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 25th, 2018 Company Industry JurisdictionWARRANT AGENCY AGREEMENT, dated as of September 25, 2018 (“Agreement”), between Titan Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Warrant Agent”).
ContractCommon Stock Purchase Warrant • September 25th, 2018 • Titan Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 25th, 2018 Company Industry JurisdictionTHE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER THAN (I) A.G.P./ALLIANCE GLOBAL PARTNERS OR AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF A.G.P./ALLIANCE GLOBAL PARTNERS OR OF ANY SUCH UNDERWRITER OR SELECTED DEALER.